AJP - Heart BIOPAC complete lab solutions
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 294: H775-H784, 2008. First published November 30, 2007; doi:10.1152/ajpheart.00841.2007
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/2/H775    most recent
00841.2007v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (2)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Bassil, M.
Right arrow Articles by Anand-Srivastava, M. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bassil, M.
Right arrow Articles by Anand-Srivastava, M. B.

Peroxynitrite inhibits the expression of Gi{alpha} protein and adenylyl cyclase signaling in vascular smooth muscle cells

Marcel Bassil, Yuan Li, and Madhu B. Anand-Srivastava

Department of Physiology, Faculty of Medicine, and Groupe de Recherche sur le Système Nerveux Autonome, University of Montreal, Montreal, Quebec, Canada

Submitted 18 July 2007 ; accepted in final form 20 November 2007

We previously showed that S-nitroso-N-acetylpenicillamine, a nitric oxide donor, decreased the levels and functions of Gi{alpha} proteins by formation of peroxynitrite (ONOO) in vascular smooth muscle cells (VSMC). The present studies were undertaken to investigate whether ONOO can modulate the expression of Gi{alpha} protein and associated adenylyl cyclase signaling in VSMC. Treatment of A-10 and aortic VSMC with ONOO for 24 h decreased the expression of Gi{alpha}-2 and Gi{alpha}-3, but not Gs{alpha}, protein in a concentration-dependent manner; expression was restored toward control levels by 111Mn-tetralis(benzoic acid porphyrin) and uric acid, but not by 1H[1,2,4]oxadiazole[4,3-a]quinoxaline-1-one (ODQ) and KT-5823. cGMP levels were increased by ~50% and 150% by 0.1 and 0.5 mM ONOO, respectively, and attenuated toward control levels by ODQ. In addition, 0.5 mM ONOO attenuated the inhibition of adenylyl cyclase by ANG II and C-type atrial natriuretic peptide (C-ANP4–23), as well as the inhibition of forskolin-stimulated adenylyl cyclase activity by GTP{gamma}S, whereas, the Gs-mediated stimulations were augmented. In addition, 0.5 mM ONOO decreased phosphorylation of ERK1/2 and p38 MAP kinase and enhanced JNK phosphorylation but did not affect AKT1/3 phosphorylation. These results suggest that ONOO decreased the expression of Gi proteins and associated functions in VSMC through a cGMP-independent mechanism and may involve the MAP kinase signaling pathway.

G protein; mitogen-activated protein kinase



Address for reprint requests and other correspondence: M. B. Anand-Srivastava, Dept. of Physiology, Faculty of Medicine, Univ. of Montreal, CP 6128, Succ. Centreville, Montreal, QC, Canada H3C 3J7 (e-mail: madhu.anand-srivastava{at}umontreal.ca)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
Y. Li, M. Descorbeth, and M. B. Anand-Srivastava
Role of oxidative stress in high glucose-induced decreased expression of Gi{alpha} proteins and adenylyl cyclase signaling in vascular smooth muscle cells
Am J Physiol Heart Circ Physiol, June 1, 2008; 294(6): H2845 - H2854.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.